Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-25 09:41 am Purchase |
2021-01-14 | 13G | Lantern Pharma Inc. LTRN |
Empery Asset Management, LP | 700,000 6.660% |
700,000 (New Position) |
Filing History |
| 2021-01-21 2:28 pm Purchase |
2021-01-15 | 13G | Titan Pharmaceuticals, Inc. TTNP |
Empery Asset Management, LP | 47,229 6.910% |
47,229 (New Position) |
Filing History |
| 2021-01-20 11:14 am Sale |
2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX |
Empery Asset Management, LP | 33,223 4.570% |
-8,444 (-20.27%) |
Filing History |
| 2021-01-20 11:11 am Unchanged |
2021-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
Empery Asset Management, LP | 44 4.990% |
0 (Unchanged) |
Filing History |
| 2021-01-20 11:10 am Sale |
2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Empery Asset Management, LP | 336 1.050% |
-1,664 (-83.21%) |
Filing History |
| 2021-01-20 11:08 am Purchase |
2020-12-31 | 13G | enVVeno Medical Corporation HJLI |
Empery Asset Management, LP | 185,868 4.990% |
185,868 (New Position) |
Filing History |
| 2021-01-20 11:05 am Purchase |
2020-12-31 | 13G | Genius Brands International, Inc. GNUS |
Empery Asset Management, LP | 1,000,000 3.750% |
67,143 (+7.20%) |
Filing History |
| 2021-01-20 11:03 am Purchase |
2020-12-31 | 13G | Globus Maritime Limited GLBS |
Empery Asset Management, LP | 372,494 4.990% |
372,494 (New Position) |
Filing History |
| 2021-01-20 11:01 am Sale |
2020-12-31 | 13G | Second Sight Medical Products, Inc. EYES |
Empery Asset Management, LP | 0 0.000% |
-733,333 (Position Closed) |
Filing History |
| 2021-01-19 09:58 am Purchase |
2021-01-14 | 13G | Viveve Medical, Inc. VIVE |
Empery Asset Management, LP | 1,029,411 9.960% |
1,029,411 (New Position) |
Filing History |
| 2021-01-14 09:02 am Purchase |
2021-01-10 | 13G | Applied DNA Sciences, Inc. APDN |
Empery Asset Management, LP | 32 6.420% |
32 (+6880.80%) |
Filing History |
| 2021-01-14 09:00 am Purchase |
2021-01-08 | 13G | Zevra Therapeutics, Inc. ZVRA |
Empery Asset Management, LP | 1,230,000 9.990% |
1,230,000 (New Position) |
Filing History |
| 2021-01-14 09:00 am Purchase |
2021-01-06 | 13G | Atossa Therapeutics, Inc. ATOS |
Empery Asset Management, LP | 4,760,500 5.320% |
4,760,500 (New Position) |
Filing History |
| 2021-01-13 09:03 am Purchase |
2020-12-31 | 13G | Castor Maritime Inc. CTRM |
Empery Asset Management, LP | 277,333 9.910% |
130,000 (+88.24%) |
Filing History |
| 2021-01-13 09:03 am Sale |
2020-12-31 | 13G | CELLECT BIOTECHNOLOGY LTD SPON APOP |
Empery Asset Management, LP | 185,200 0.050% |
-32,114,800 (-99.43%) |
Filing History |
| 2021-01-13 09:02 am Sale |
2020-12-31 | 13G | Allena Pharmaceuticals, Inc. ALNAQ |
Empery Asset Management, LP | 0 0.000% |
-2,792,683 (Position Closed) |
Filing History |
| 2021-01-13 09:02 am Unchanged |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Empery Asset Management, LP | 61,333 4.990% |
0 (Unchanged) |
Filing History |
| 2021-01-13 09:01 am Purchase |
2020-12-31 | 13G | Baudax Bio, Inc. BXRX |
Empery Asset Management, LP | 714 2.600% |
714 (New Position) |
Filing History |
| 2021-01-13 09:01 am Purchase |
2020-12-31 | 13G | Nuwellis, Inc. NUWE |
Empery Asset Management, LP | 137 4.990% |
137 (New Position) |
Filing History |
| 2021-01-13 09:00 am Sale |
2020-12-31 | 13G | Aethlon Medical, Inc. AEMD |
Empery Asset Management, LP | 82,502 4.990% |
-21,587 (-20.74%) |
Filing History |